NEW YORK – Chinese precision oncology company Genetron Health has formed a strategic partnership with Beijing InnoCare Pharma Tech (InnoCare) to provide clinical trial genomic testing and companion diagnostic development services for InnoCare's biomarker-driven oncology drug development.
Additional details of the agreement were not disclosed.
Genetron, based in Beijing, provides comprehensive genomic profiling services for drug research and development.